60NANB23D119

Purpose/Scope: The University of Kansas Cancer Center received Comprehensive Cancer Center designation by the National Cancer Institute in 2022. This is the highest level of recognition awarded by the NCI.

The University of Kansas Cancer Center will begin new construction on a combination of 200,000GSF of clinical space and 250,000GSF of research space for a total of 450,000GSF. The proposed NIST funded project will provide construction of the 7th floor research wing and will be a total of 33,000GSF of research and research office space.

Activities to be performed: Achieving NCI Comprehensive Cancer Center designation was not the end of our journey. For leadership of the University of Kansas and the University of Kansas Health System, the work is ongoing to sustain our status as the premier academic medical center in our community, state, and region whose reputation is respected nationwide. The funding from this grant will be targeted toward the construction of one of our primary basic research floors in our new KU Cancer Center building.

Expected outcomes: This new home will put patients at the center of science and clinical care, making the KU Cancer Center a global destination for the best in cancer treatment. Cancer projections underscore our urgency to build a new centralized research facility. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. In order to continue to grow our Cancer Center and expand our focus on immunotherapy and other promising new cancer therapeutics, we will need to expand our research and clinical teams. For example, with the construction of this building, we plan to add 26 new investigators over the next ten years. This will be critical to our efforts to effectively serve our catchment area. It is also important to note that a primary purpose of our new building is to co-locate our basic scientists, our clinicians, and our population health investigators in a single building which will allow increased interactions and collaborations.

Intended beneficiaries: For the people in our region, comprehensive designation means greater access to leading-edge treatments, including clinical trials, as well as the best and brightest minds in cancer. A facility containing nearly all basic, translational and population science faculty adjacent to our newly constructed oncology in-patient tower will be a significant catalyst for further growth and strengthening of our center. This will be particularly important for our diversity, equity, inclusion and accessibility efforts as many of our population health researchers focus their work on underserved and marginalized population groups.

Subrecipient activities: With a project as ambitious and complex as this new KU Cancer Center building, community partners, engineering and construction subrecipients are absolutely necessary for the overall vision and execution.

Useful life: 20 years.

University Of Kansas Medical Center Research Institute

11.617 - Congressionally-Identified Projects

National Institute of Standards and Technology (NIST) [DOC]

Kansas City, Kansas 66103-2937 United States

Single Zip Code

None